On Tuesday, Strive’s CEO Matthew Ryan Cole purchased 500,000 shares of ASST at $0.92 each, totaling $459,350. During the trading session, ASST reached a high of $1.07, placing Cole’s investment up about 16.5%. This marks his second buy in the past year, having previously acquired $415,999 shares at $0.81 each.
Also on Tuesday, Director David J. Matlin bought 33,333 shares of Clene for $216,664, at a cost of $6.50 per share. This transaction is Matlin’s first insider buy in over a year. Currently, Clene’s stock is trading at a low of $4.95, representing a 23.8% drop from Matlin’s purchase price.
